| Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia SL Maude, TW Laetsch, J Buechner, S Rives, M Boyer, H Bittencourt, ... New England Journal of Medicine 378 (5), 439-448, 2018 | 4999 | 2018 |
| Childhood acute lymphoblastic leukemia: progress through collaboration CH Pui, JJ Yang, SP Hunger, R Pieters, M Schrappe, A Biondi, A Vora, ... Journal of Clinical Oncology 33 (27), 2938-2948, 2015 | 1014 | 2015 |
| Outcome of treatment in children with Philadelphia chromosome–positive acute lymphoblastic leukemia M Aricò, MG Valsecchi, B Camitta, M Schrappe, J Chessells, A Baruchel, ... New England Journal of Medicine 342 (14), 998-1006, 2000 | 769 | 2000 |
| Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials N Boissel, MF Auclerc, V Lhéritier, Y Perel, X Thomas, T Leblanc, ... Journal of Clinical Oncology 21 (5), 774-780, 2003 | 752 | 2003 |
| L‐asparaginase treatment in acute lymphoblastic leukemia A focus on Erwinia asparaginase R Pieters, SP Hunger, J Boos, C Rizzari, L Silverman, A Baruchel, ... Cancer 117 (2), 238-249, 2011 | 672 | 2011 |
| Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region CH Pui, PS Gaynon, JM Boyett, JM Chessells, A Baruchel, W Kamps, ... The Lancet 359 (9321), 1909-1915, 2002 | 496 | 2002 |
| Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML) N Boissel, H Leroy, B Brethon, N Philippe, S De Botton, A Auvrignon, ... Leukemia 20 (6), 965-970, 2006 | 459 | 2006 |
| Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18–20 September 2008 M Brüggemann, A Schrauder, T Raff, H Pfeifer, M Dworzak, OG Ottmann, ... Leukemia 24 (3), 521-535, 2010 | 453 | 2010 |
| HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL) J Soulier, E Clappier, JM Cayuela, A Regnault, M García-Peydró, ... Blood 106 (1), 274-286, 2005 | 440 | 2005 |
| Outcomes after induction failure in childhood acute lymphoblastic leukemia M Schrappe, SP Hunger, CH Pui, V Saha, PS Gaynon, A Baruchel, ... New England Journal of Medicine 366 (15), 1371-1381, 2012 | 359 | 2012 |
| Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey MO Chandesris, I Melki, A Natividad, A Puel, C Fieschi, L Yun, ... Medicine 91 (4), e1-e19, 2012 | 342 | 2012 |
| NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern IHIM Hollink, MM van den Heuvel-Eibrink, ST Arentsen-Peters, ... Blood, The Journal of the American Society of Hematology 118 (13), 3645-3656, 2011 | 342 | 2011 |
| A landscape of germ line mutations in a cohort of inherited bone marrow failure patients O Bluteau, M Sebert, T Leblanc, R Peffault de Latour, S Quentin, E Lainey, ... Blood, The Journal of the American Society of Hematology 131 (7), 717-732, 2018 | 319 | 2018 |
| The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T … E Clappier, W Cuccuini, A Kalota, A Crinquette, JM Cayuela, WA Dik, ... Blood, The Journal of the American Society of Hematology 110 (4), 1251-1261, 2007 | 319 | 2007 |
| Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements CH Pui, JM Chessells, B Camitta, A Baruchel, A Biondi, JM Boyett, ... Leukemia 17 (4), 700-706, 2003 | 312 | 2003 |
| Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies R Benjamin, C Graham, D Yallop, A Jozwik, OC Mirci-Danicar, G Lucchini, ... The Lancet 396 (10266), 1885-1894, 2020 | 302 | 2020 |
| Clinical outcome of children with newly diagnosed Philadelphia chromosome–positive acute lymphoblastic leukemia treated between 1995 and 2005 M Arico, M Schrappe, SP Hunger, WL Carroll, V Conter, S Galimberti, ... Journal of clinical oncology 28 (31), 4755-4761, 2010 | 298 | 2010 |
| BET inhibitor OTX015 targets BRD2 and BRD4 and decreases c-MYC in acute leukemia cells MM Coudé, T Braun, J Berrou, M Dupont, S Bertrand, A Masse, E Raffoux, ... Oncotarget 6 (19), 17698, 2015 | 270 | 2015 |
| New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children N Aladjidi, G Leverger, T Leblanc, MQ Picat, G Michel, Y Bertrand, ... haematologica 96 (5), 655, 2011 | 261 | 2011 |
| Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options U Fischer, M Forster, A Rinaldi, T Risch, S Sungalee, HJ Warnatz, ... Nature genetics 47 (9), 1020-1029, 2015 | 255 | 2015 |
